SARS-CoV-2 Omicron Variant Genomic and Phylogenetic Analysis in Iraqi Kurdistan Region

Omicron variants have been classified as Variants of Concern (VOC) by the World Health Organization (WHO) ever since they first emerged as a result of a significant mutation in this variant, which showed to have an impact on transmissibility and virulence of the virus, as evidenced by the ongoing modifications in the SARS-CoV-2 virus. As a global pandemic, the Omicron variant also spread among the Kurdish population. This study aimed to analyze different strains from different cities of the Kurdistan region of Iraq to show the risk of infection and the impact of the various mutations on immune responses and vaccination. A total of 175 nasopharyngeal/oropharyngeal specimens were collected at West Erbil Emergency Hospital and confirmed for SARS-CoV-2 infection by RT-PCR. The genomes of the samples were sequenced using the Illumina COVID-Seq Method. The genome analysis was established based on previously published data in the GISAID database and compared to previously detected mutations in the Omicron variants, and that they belong to the BA.1 lineage and include most variations determined in other studies related to transmissibility, high infectivity and immune escape. Most of the mutations were found in the RBD (receptor binding domain), the region related to the escape from humoral immunity. Remarkably, these point mutations (G339D, S371L, S373P, S375F, T547K, D614G, H655Y, N679K and N969K) were also determined in this study, which were unique, and their impact should be addressed more. Overall, the Omicron variants were more contagious than other variants. However, the mortality rate was low, and most infectious cases were asymptomatic. The next step should address the potential of Omicron variants to develop the next-generation COVID-19 vaccine.

[1]  Xiangrong Song,et al.  Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response , 2022, Signal Transduction and Targeted Therapy.

[2]  T. Zhou,et al.  Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2 , 2022, Cell Host & Microbe.

[3]  C. Chakraborty,et al.  Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions , 2022, GeroScience.

[4]  C. Zheng,et al.  Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines , 2022, Journal of medical virology.

[5]  R. Sasisekharan,et al.  Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain , 2022, Cell Reports Medicine.

[6]  V. Lounnas,et al.  THE OMICRON VARIANT BREAKS THE EVOLUTIONARY LINEAGE OF SARS-COV2 VARIANTS , 2021, International Journal of Research -GRANTHAALAYAH.

[7]  G. Cheng,et al.  Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa , 2021, Journal of medical virology.

[8]  M. Kandeel,et al.  Omicron variant genome evolution and phylogenetics , 2021, Journal of medical virology.

[9]  Yuanlin Song,et al.  Preparation for the challenge of heavily mutated Omicron variant , 2021, Clinical and translational medicine.

[10]  J. Adjaye,et al.  Detailed phylogenetic analysis tracks transmission of distinct SARS-COV-2 variants from China and Europe to West Africa , 2021, Scientific Reports.

[11]  G. Shen,et al.  S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis , 2021, Signal Transduction and Targeted Therapy.

[12]  O. Dym,et al.  SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution , 2021, Nature Microbiology.

[13]  G. Narasimhan,et al.  Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion , 2021, bioRxiv.

[14]  William T. Harvey,et al.  Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination , 2021, medRxiv.

[15]  William T. Harvey,et al.  Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 , 2021, Cell Reports.

[16]  M. Beltramello,et al.  N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 , 2021, Cell.

[17]  G. Cheng,et al.  One year of SARS-CoV-2 evolution , 2021, Cell Host & Microbe.

[18]  Caizheng Yu,et al.  Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients , 2020, Cell Reports.

[19]  A. Walls,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[20]  V. Souza,et al.  The Geographic Structure of Viruses in the Cuatro Ciénegas Basin, a Unique Oasis in Northern Mexico, Reveals a Highly Diverse Population on a Small Geographic Scale , 2018, Applied and Environmental Microbiology.

[21]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[22]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[23]  Zhengwei Zhu,et al.  CD-HIT: accelerated for clustering the next-generation sequencing data , 2012, Bioinform..